Cargando…

Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions

BACKGROUND: Survival rates following a diagnosis of cancer vary between countries. The International Cancer Benchmarking Partnership (ICBP), a collaboration between six countries with primary care led health services, was set up in 2009 to investigate the causes of these differences. Module 3 of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Peter W, Hamilton, Willie, Aldersey, Kate, Barisic, Andriana, Dawes, Martin, Foot, Catherine, Grunfeld, Eva, Hart, Nigel, Neal, Richard D, Pirotta, Marie, Sisler, Jeffrey, Thulesius, Hans, Vedsted, Peter, Young, Jane, Rubin, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073814/
https://www.ncbi.nlm.nih.gov/pubmed/24938306
http://dx.doi.org/10.1186/1471-2296-15-122
_version_ 1782323146763796480
author Rose, Peter W
Hamilton, Willie
Aldersey, Kate
Barisic, Andriana
Dawes, Martin
Foot, Catherine
Grunfeld, Eva
Hart, Nigel
Neal, Richard D
Pirotta, Marie
Sisler, Jeffrey
Thulesius, Hans
Vedsted, Peter
Young, Jane
Rubin, Greg
author_facet Rose, Peter W
Hamilton, Willie
Aldersey, Kate
Barisic, Andriana
Dawes, Martin
Foot, Catherine
Grunfeld, Eva
Hart, Nigel
Neal, Richard D
Pirotta, Marie
Sisler, Jeffrey
Thulesius, Hans
Vedsted, Peter
Young, Jane
Rubin, Greg
author_sort Rose, Peter W
collection PubMed
description BACKGROUND: Survival rates following a diagnosis of cancer vary between countries. The International Cancer Benchmarking Partnership (ICBP), a collaboration between six countries with primary care led health services, was set up in 2009 to investigate the causes of these differences. Module 3 of this collaboration hypothesised that an association exists between the readiness of primary care physicians (PCP) to investigate for cancer – the ‘threshold’ risk level at which they investigate or refer to a specialist for consideration of possible cancer – and survival for that cancer (lung, colorectal and ovarian). We describe the development of an international survey instrument to test this hypothesis. METHODS: The work was led by an academic steering group in England. They agreed that an online survey was the most pragmatic way of identifying differences between the jurisdictions. Research questions were identified through clinical experience and expert knowledge of the relevant literature. A survey comprising a set of direct questions and five clinical scenarios was developed to investigate the hypothesis. The survey content was discussed and refined concurrently and repeatedly with international partners. The survey was validated using an iterative process in England. Following validation the survey was adapted to be relevant to the health systems operating in other jurisdictions and translated into Danish, Norwegian and Swedish, and into Canadian and Australian English. RESULTS: This work has produced a survey with face, content and cross cultural validity that will be circulated in all six countries. It could also form a benchmark for similar surveys in countries with similar health care systems. CONCLUSIONS: The vignettes could also be used as educational resources. This study is likely to impact on healthcare policy and practice in participating countries.
format Online
Article
Text
id pubmed-4073814
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40738142014-06-28 Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions Rose, Peter W Hamilton, Willie Aldersey, Kate Barisic, Andriana Dawes, Martin Foot, Catherine Grunfeld, Eva Hart, Nigel Neal, Richard D Pirotta, Marie Sisler, Jeffrey Thulesius, Hans Vedsted, Peter Young, Jane Rubin, Greg BMC Fam Pract Research Article BACKGROUND: Survival rates following a diagnosis of cancer vary between countries. The International Cancer Benchmarking Partnership (ICBP), a collaboration between six countries with primary care led health services, was set up in 2009 to investigate the causes of these differences. Module 3 of this collaboration hypothesised that an association exists between the readiness of primary care physicians (PCP) to investigate for cancer – the ‘threshold’ risk level at which they investigate or refer to a specialist for consideration of possible cancer – and survival for that cancer (lung, colorectal and ovarian). We describe the development of an international survey instrument to test this hypothesis. METHODS: The work was led by an academic steering group in England. They agreed that an online survey was the most pragmatic way of identifying differences between the jurisdictions. Research questions were identified through clinical experience and expert knowledge of the relevant literature. A survey comprising a set of direct questions and five clinical scenarios was developed to investigate the hypothesis. The survey content was discussed and refined concurrently and repeatedly with international partners. The survey was validated using an iterative process in England. Following validation the survey was adapted to be relevant to the health systems operating in other jurisdictions and translated into Danish, Norwegian and Swedish, and into Canadian and Australian English. RESULTS: This work has produced a survey with face, content and cross cultural validity that will be circulated in all six countries. It could also form a benchmark for similar surveys in countries with similar health care systems. CONCLUSIONS: The vignettes could also be used as educational resources. This study is likely to impact on healthcare policy and practice in participating countries. BioMed Central 2014-06-17 /pmc/articles/PMC4073814/ /pubmed/24938306 http://dx.doi.org/10.1186/1471-2296-15-122 Text en Copyright © 2014 Rose et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rose, Peter W
Hamilton, Willie
Aldersey, Kate
Barisic, Andriana
Dawes, Martin
Foot, Catherine
Grunfeld, Eva
Hart, Nigel
Neal, Richard D
Pirotta, Marie
Sisler, Jeffrey
Thulesius, Hans
Vedsted, Peter
Young, Jane
Rubin, Greg
Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions
title Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions
title_full Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions
title_fullStr Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions
title_full_unstemmed Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions
title_short Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions
title_sort development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073814/
https://www.ncbi.nlm.nih.gov/pubmed/24938306
http://dx.doi.org/10.1186/1471-2296-15-122
work_keys_str_mv AT rosepeterw developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT hamiltonwillie developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT alderseykate developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT barisicandriana developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT dawesmartin developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT footcatherine developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT grunfeldeva developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT hartnigel developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT nealrichardd developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT pirottamarie developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT sislerjeffrey developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT thulesiushans developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT vedstedpeter developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT youngjane developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions
AT rubingreg developmentofasurveyinstrumenttoinvestigatetheprimarycarefactorsrelatedtodifferencesincancerdiagnosisbetweeninternationaljurisdictions